Search research articles
Contact Us
Filters
Showing results (221-230 of 279) with videos related to
Page
of 28
Sort By:
Neuro-Oncology
|
December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology
|
February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference
Roger J Packer, Antonio Iavarone, David T W Jones, et al.
Developmental Cell
|
August 24, 2021
Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors
Emmanuelle S Jecrois, Wang Zheng, Miriam Bornhorst, et al.
Neuro-Oncology
|
April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study
Mark W Kieran, Roger J Packer, Arzu Onar, et al.
American Journal of Medical Genetics. Part A
|
April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis
Jaishri O Blakeley, Annette Bakker, Anne Barker, et al.
JAMA Oncology
|
July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group
Sarah E S Leary, Roger J Packer, Yimei Li, et al.
Neuro-Oncology
|
March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
Neuro-Oncology Advances
|
October 22, 2025
Challenges in diagnostics and treatment of infant-type hemispheric gliomas
Ludmila Papusha, Margarita Zaytseva, Maria Senchenko, et al.
Annals of Neurology
|
April 18, 2014
Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 279) with videos related to
Sort By:
Page
of 28
Neuro-Oncology
|
December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology
|
February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference
Roger J Packer, Antonio Iavarone, David T W Jones, et al.
Developmental Cell
|
August 24, 2021
Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors
Emmanuelle S Jecrois, Wang Zheng, Miriam Bornhorst, et al.
Neuro-Oncology
|
April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee
Katherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study
Mark W Kieran, Roger J Packer, Arzu Onar, et al.
American Journal of Medical Genetics. Part A
|
April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis
Jaishri O Blakeley, Annette Bakker, Anne Barker, et al.
JAMA Oncology
|
July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group
Sarah E S Leary, Roger J Packer, Yimei Li, et al.
Neuro-Oncology
|
March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
Neuro-Oncology Advances
|
October 22, 2025
Challenges in diagnostics and treatment of infant-type hemispheric gliomas
Ludmila Papusha, Margarita Zaytseva, Maria Senchenko, et al.
Annals of Neurology
|
April 18, 2014
Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
Page
of 28